CIDEIM, con el propósito de difundir los resultados de las investigaciones, entre las comunidades científicas nacionales e internacionales, y en la sociedad da a conocer las publicaciones del primer semestre del 2021.

Dentro de las temáticas que abordan las publicaciones se encuentran: innovación social, fortalecimiento de capacidad de investigación, y las enfermedades que se investigan desde la institución como malaria, leishmaniasis, tuberculosis, sífilis y otras Infecciones de Transmisión Sexual (ITS).

PUBLICACIONES

Oviedo Sarmiento OJ; Castro MM; Orobio Lerma Y; Vargas Bernal L; Navarro A; Alexander NDE. 2021. Data management plan for a community-level study of the hidden burden of cutaneous leishmaniasis in Colombia. BMC Res Notes. 2021 May 31;14(1):213. doi: 10.1186/s13104-021-05618-4. PMID: 34059128 PMCID: PMC8165780

Data management plan for a community-level study of the hidden burden of cutaneous leishmaniasis in Colombia.

Gomez MA; Navas A; Prieto M; Giraldo-Parra L; Cossio A; Alexander N; Saravia NG. 2021. Immuno-pharmacokinetics of meglumine antimoniate in patients with cutaneous leishmaniasis caused by Leishmania Viannia. Clin Infect Dis. 2021 May 18;72(10):e484-e492. doi: 10.1093/cid/ciaa1206. PMID:32818964 PMCID: PMC8130027

Immuno-pharmacokinetics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis Caused by Leishmania (Viannia).

Cossio A; Jojoa J; Castro MM; Castillo RM; Osorio L; Shelite TR; Saravia NG; Melby PC; Travi BL. 2021. Diagnostic performance of a Recombinant Polymerase Amplification Test - Lateral Flow (RPA-LF) for cutaneous leishmaniasis in an endemic setting of Colombia. PLoS Negl Trop Dis. 2021 Apr 28;15(4):e0009291. doi: 10.1371/journal.pntd.0009291. PMID: 33909619. PMCID: PMC8081229

Diagnostic performance of a Recombinant Polymerase Amplification Test-Lateral Flow (RPA-LF) for cutaneous leishmaniasis in an endemic setting of Colombia.

MalariaGEN, Ahouidi A, Ali M et al. 2021. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Res 2021, 6:42 (https://doi.org/10.12688/wellcomeopenres.16168.1). eCollection 2021. PMID: 33824913 PMCID: PMC8008441. Diego Echeverry

An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples.

Garay-Baquero DJ; Rebellon-Sanchez DE; Prieto MD; Parra-Giraldo L; Navas A; Atkinson S; McDouglas S; Gomez MA. 2021. Inductively coupled plasma mass spectrometry method for plasma and intracellular antimony quantification applied to pharmacokinetics of meglumine antimoniate. Bioanalysis. 2021 Apr;13(8):655-667. doi: 10.4155/bio-2021-0013. Epub 2021 Apr 8. PMID: 33829863 Free article

Inductively coupled plasma mass spectrometry method for plasma and intracellular antimony quantification applied to pharmacokinetics of meglumine antimoniate.

López-Medina E; Rojas CA; Calle-Giraldo JP; Alexander N; Hurtado IC; Davalos DM; Lopez P; Barco C; Libreros D; Arias A; Lesmes MC; Pinzon E; Ortiz VA. 2021. Risks of Adverse Childhood Outcomes According to Prenatal Time of Exposure to Zika Virus: Assessment in a Cohort Exposed to Zika During an Outbreak in Colombia. J Pediatric Infect Dis Soc. March 2021. 10(3):337-3402020;piaa042. doi:10.1093/jpids/piaa042. PMID: 32415777

Risks of Adverse Childhood Outcomes According to Prenatal Time of Exposure to Zika Virus: Assessment in a Cohort Exposed to Zika During an Outbreak in Colombia.

Rubiano L; Alexander N; Castillo RM; Martinez AJ; Garcia JA; Arango JD; Vargas L; Madriñan P; Hurtado LR; Orobio Y; Rojas CA; del Corral H; Navarro A; Saravia NG; Aronoff-Spencer E. 2021. Adaptation and performance of a mobile application for early detection of cutaneous Leishmaniasis. PLoS Negl Trop Dis. 2021 Feb 11;15(2):e0008989. doi: 10.1371/journal.pntd.0008989. eCollection 2021 Feb. PMID: 33571192. PMCID: PMC6211619

Adaptation and performance of a mobile application for early detection of cutaneous leishmaniasis.

Diaz G; Victoria A; Meyer A; Niño Y; Luna L; Ferro B; Davis JL. 2021. Evaluating the Quality of Tuberculosis Contact Investigation in Cali, Colombia: A Retrospective Cohort Study. Am J Trop Med Hyg. 2021 Feb 22:tpmd200809. doi: 10.4269/ajtmh.20-0809. PMID: 33617470. PMCID: PMC8045602 (available on 2022-04-01)

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335913/

Jamrozik E; Littler K; Bull S; Emerson C; Kang G; Kapulu M; Rey E; Saenz C; Shah S; Smith PG; Upshur R; Weijer C; Selgelid MJ.; for the WHO Working Group for Guidance on Human Challenge Studies in COVID-19. 2021. Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group. Vaccine. doi.org/10.1016/j.vaccine.2020.10.075. Vaccine. 2021 Jan 22;39(4):633-640. PMID: 33341309 PMCID: PMC7598752

Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.

Si desea conocer más de nuestras publicaciones ingrese aquí. A continuación, escriba la palabra CIDEIM y filtre la búsqueda según su interés, la mayoría son de libre acceso.

Más información:

Beatriz Herrera This e-mail address is being protected from spambots. You need JavaScript enabled to view it